HUT71838A - Use of biologically active ureido derivatives useful in the treatment of lentivirus-induced disease for producing pharmaceutical compositions - Google Patents

Use of biologically active ureido derivatives useful in the treatment of lentivirus-induced disease for producing pharmaceutical compositions

Info

Publication number
HUT71838A
HUT71838A HU9500120A HU9500120A HUT71838A HU T71838 A HUT71838 A HU T71838A HU 9500120 A HU9500120 A HU 9500120A HU 9500120 A HU9500120 A HU 9500120A HU T71838 A HUT71838 A HU T71838A
Authority
HU
Hungary
Prior art keywords
lentivirus
treatment
pharmaceutical compositions
biologically active
derivatives useful
Prior art date
Application number
HU9500120A
Other languages
Hungarian (hu)
Other versions
HU9500120D0 (en
HU216834B (en
Inventor
Nicola Mongelli
Marina Ciomei
Maria Grandi
Giovanni Biasoli
Maria Cristina Geroni
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of HU9500120D0 publication Critical patent/HU9500120D0/en
Publication of HUT71838A publication Critical patent/HUT71838A/en
Publication of HU216834B publication Critical patent/HU216834B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU9500120A 1993-04-16 1994-03-29 Use of pyrrolyl- ureido derivatives useful in the treatment of lentivirus-induced disease for producing pharmaceutical compositions HU216834B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939307948A GB9307948D0 (en) 1993-04-16 1993-04-16 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease

Publications (3)

Publication Number Publication Date
HU9500120D0 HU9500120D0 (en) 1995-03-28
HUT71838A true HUT71838A (en) 1996-02-28
HU216834B HU216834B (en) 1999-09-28

Family

ID=10733998

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9500120A HU216834B (en) 1993-04-16 1994-03-29 Use of pyrrolyl- ureido derivatives useful in the treatment of lentivirus-induced disease for producing pharmaceutical compositions

Country Status (15)

Country Link
EP (1) EP0646004A1 (en)
JP (1) JPH07508044A (en)
KR (1) KR950701812A (en)
AU (1) AU670194B2 (en)
CA (1) CA2137148A1 (en)
CZ (1) CZ282988B6 (en)
GB (1) GB9307948D0 (en)
HU (1) HU216834B (en)
IL (1) IL109235A (en)
NO (1) NO307126B1 (en)
PL (1) PL306798A1 (en)
RU (1) RU2142798C1 (en)
TW (1) TW308593B (en)
UA (1) UA42693C2 (en)
WO (1) WO1994023718A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9504065D0 (en) * 1995-03-01 1995-04-19 Pharmacia Spa Poly-pyrrolecarboxamidonaphthalenic acid derivatives
GB9602721D0 (en) * 1996-02-09 1996-04-10 Pharmacia Spa Biologically active ureido derivatives useful in the treatment of multiple sclerosis
GB2310207A (en) * 1996-02-15 1997-08-20 Pharmacia Spa Antiviral ureido derivatives of substituted heterocyclic compounds
GB9713733D0 (en) * 1997-06-27 1997-09-03 Pharmacia & Upjohn Spa Poly-branched polycarboxamido compounds
EP3381897A1 (en) 2017-03-27 2018-10-03 Leadiant Biosciences SA Derivatives of the disodium 2,2'-{carbonylbis[imino-3,1-phenylenecarbonylimino(1-methyl-1h-pyrrole-4,2-diyl)carbonylimino]}dinaphthalene-1,5-disulfonate salt and related compounds as heparanase inhibitors for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9000644D0 (en) * 1990-01-11 1990-03-14 Erba Carlo Spa New ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds
AU1224392A (en) * 1991-02-06 1992-09-07 Synphar Laboratories, Inc. Oligopeptide antiretroviral agents

Also Published As

Publication number Publication date
PL306798A1 (en) 1995-04-18
IL109235A (en) 1998-09-24
NO944809D0 (en) 1994-12-12
CZ10795A3 (en) 1995-09-13
AU6537194A (en) 1994-11-08
UA42693C2 (en) 2001-11-15
TW308593B (en) 1997-06-21
KR950701812A (en) 1995-05-17
EP0646004A1 (en) 1995-04-05
JPH07508044A (en) 1995-09-07
HU9500120D0 (en) 1995-03-28
NO944809L (en) 1994-12-12
AU670194B2 (en) 1996-07-04
CA2137148A1 (en) 1994-10-27
GB9307948D0 (en) 1993-06-02
IL109235A0 (en) 1994-07-31
CZ282988B6 (en) 1997-12-17
RU2142798C1 (en) 1999-12-20
RU94046312A (en) 1996-10-20
HU216834B (en) 1999-09-28
WO1994023718A1 (en) 1994-10-27
NO307126B1 (en) 2000-02-14

Similar Documents

Publication Publication Date Title
HUP0000558A3 (en) Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases
HUP9903489A3 (en) Use of epinastine for the preparation of pharmaceutical compositions treating pain
HUT75089A (en) Compositions containing hyaluronic acid or it's derivatives and pharmaceutical active agent
IL122733A0 (en) Pharmaceutical compositions for use in the treatment of allergic asthma
ZA899176B (en) Use of acetyl d-carnitine in the therapeutic treatment of glaucoma and pharmaceutical compositions useful in such treatment
HUT64013A (en) Process for producing hiv-inhibiting phenylacetamide derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT74387A (en) Pseudodipeptide products having imidazole group and their use for producing pharmaceutical compositions
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
IL105942A0 (en) Biologically active eburnamenine derivatives,their preparation and pharmaceutical compositions containing them
HUP0004331A3 (en) Use of phanquinone for producing pharmaceutical compositions for the treatment of alzheimer's disease and combined pharmaceutical compositions containing it
HUP9900924A3 (en) Substituted 1 betha-d-arabinofuranosylcytosine derivatives and use of the same for producing pharmaceutical compositions having antitumor activity
HUP0001526A3 (en) Use of nucleozides for producing pharmaceutical compositions for cytokine related treatments of disease and the pharmaceutical compositions
HUT62760A (en) Nematocidal compositions comprising pyrimidine derivatives as active ingredient and process for producing the active ingredient
HUT71838A (en) Use of biologically active ureido derivatives useful in the treatment of lentivirus-induced disease for producing pharmaceutical compositions
PL305981A1 (en) Biologically active ureido derivatives useful as ananti-metastatic agents
PL327168A1 (en) Pharmaceutical compositions suitable for use in treatment of diseases associated with venal lesions and/or inflammatore oedema and novel compounds used in such compositions
AU7793791A (en) Pharmaceutical composition for use in treating pain
HUT60711A (en) Process for producing new crystalline (s)-norfluoxetine and pharmaceutical composition comprising the active ingredient
GR3033332T3 (en) Biologically active ureido derivatives useful in the treatment of multiple sclerosis
HUT61878A (en) Nematocidal compositions comprising pyrimidine derivatives as active ingredient and process for producing the active ingredient
HUT49364A (en) Process for producing sialosylglyceride derivatives and pharmaceutical compositions comprising such active ingredient
IL105569A (en) Pharmaceutical compositions containing remacemide for the treatment of parkinson's disease
HUT53108A (en) Process for producing penem derivatives and pharmaceutical compositions comprising such active ingredient
HUT61776A (en) Process for producing 3' and/or 4' oh-modificated elsamycin derivatives and pharmaceutical compositions containing them as active components
HUP9802450A3 (en) Use of prostane derivatives and the combination thereof for preparing pharmaceutical compositions for use in treatment of bacterial infections

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee